Fei Le
Department Of Head And Neck Surgery
Nanchang, China
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Thirty years of NCI thyroid cancer research investment (1996-2025): a longitudinal portfolio analysis of funding trends, molecular target emphasis and thematic evolution.
Journal: Frontiers in oncology
Published: May 08, 2026
Targeting the AHR-IDO1-kynurenine pathway in TREM2+ macrophages restores antitumor immunity in thyroid cancer.
Journal: Frontiers in immunology
Published: March 09, 2026
Advances in Immunotherapy for Head and Neck Squamous Cell Carcinoma: Focus on PD-1/PD-L1 Blockade and Beyond.
Journal: Clinical Medicine Insights. Oncology
Published: September 15, 2025
Aggressive recurrent intestinal-type adenocarcinoma of the nasal cavity: a case report and literature review.
Journal: Frontiers in medicine
Published: October 12, 2024
MLN4924 Suppresses head and neck squamous cell carcinoma progression by inactivating the mTOR signaling pathway via the NEDD8/CUL4/TSC2 axis.
Journal: The international journal of biochemistry & cell biology
Published: July 16, 2024
miR-195-5p regulates cell proliferation, apoptosis, and invasion of thyroid cancer by targeting telomerase reverse transcriptase.
Journal: Bioengineered
Published: September 06, 2021
lncRNA ZNF674-AS1 inhibits the migration, invasion and epithelial-mesenchymal transition of thyroid cancer cells by modulating the miR-181a/SOCS4 axis.
Journal: Molecular and cellular endocrinology
Published: August 03, 2021
Integrated tissue proteome and metabolome reveal key elements and regulatory pathways in cutaneous squamous cell carcinoma.
Journal: Journal of proteomics
Published: February 07, 2021
LncRNA NCK1-AS1 in plasma distinguishes oral ulcer from early-stage oral squamous cell carcinoma.
Journal: Journal of biological research (Thessalonike, Greece)
Published: April 10, 2020
LncRNA WT1-AS Downregulates Survivin by Upregulating miR-203 in Papillary Thyroid Carcinoma.
Journal: Cancer management and research
Published: September 24, 2019
The levels of NF-κB p50 and NF-κB p65 play a role in thyroid carcinoma malignancy in vivo.
Journal: The Journal of international medical research
Published: July 18, 2018
MiR-181a promotes growth of thyroid cancer cells by targeting tumor suppressor RB1.
Journal: European review for medical and pharmacological sciences
Published: December 23, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026